Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age

por Krzysztof Lukaszuk, Amira Podolak, Grzegorz Jakiel, Jolanta Kiewisz, Izabela Woclawek-Potocka, Aron Lukaszuk, Lukasz Rabalski
Publicado 2021

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types

por Minghui Li, Jing Yuan, Gang Lv, Jacob Brown, Xiangxiang Jiang, Zhiqiang Kevin Lu
Publicado 2021

Development Trends and Suggestions of Nucleic Acid Vaccines

por Li Aihua, Yang Xuemei, Sun Yinan, Yuan Yakun, Yang Juntao
Publicado 2021

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

por Serge Goldman, Dominique Bron, Thomas Tousseyn, Irina Vierasu, Laurent Dewispelaere, Pierre Heimann, Elie Cogan, Michel Goldman
Publicado 2021

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

por Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luís Alberto Brêda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed, Roberto Badaró
Publicado 2021

Reactogenicity of BNT162b2 mRNA COVID-19 Vaccine in a Young Working Age Population: A Survey among Medical School Residents, within a Mass Vaccination Campaign, in a Regional Refer...

por Alborz Rahmani, Guglielmo Dini, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Alfredo Montecucco, Luca Pellegrini, Alessia Manca, Alexander Domnich, Angela Battistini, Bruno Kusznir Vitturi, Sonia Zacconi, Nicoletta Debarbieri, Giancarlo Icardi, Paolo Durando
Publicado 2021

Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272

por Giorgio Bozzi, Andrea Lombardi, Serena Ludovisi, Antonio Muscatello, Lara Manganaro, Dario Cattaneo, Andrea Gori, Alessandra Bandera
Publicado 2021

Cutaneous reaction reported after third Moderna COVID-19 vaccine

por Sophie H. Guénin, MSc, Mindy Kresch, BS, Emily Elbogen, PA, Mark G. Lebwohl, MD
Publicado 2021

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

por Filippo Massa, PhD, Marion Cremoni, MD, Alexandre Gérard, MD, Hanen Grabsi, Lory Rogier, Mathilde Blois, MD, Chloé Couzin, MD, Nadia Ben Hassen, Matthieu Rouleau, PhD, Susana Barbosa, PhD, Emanuela Martinuzzi, PhD, Julien Fayada, Ghislaine Bernard, MD-PhD, Guillaume Favre, MD-PhD, Paul Hofman, MD-PhD, Vincent L.M. Esnault, MD-PhD, Cecil Czerkinsky, MD-PhD, Barbara Seitz-Polski, MD-PhD, Nicolas Glaichenhaus, PhD, Antoine Sicard, MD-PhD
Publicado 2021

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine

por Davide Ferrari, Nicola Clementi, Elena Criscuolo, Alessandro Ambrosi, Francesca Corea, Chiara Di Resta, Rossella Tomaiuolo, Nicasio Mancini, Massimo Locatelli, Mario Plebani, Giuseppe Banfi
Publicado 2021

Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central...

por Arkadiusz Dziedzic, Abanoub Riad, Sameh Attia, Miloslav Klugar, Marta Tanasiewicz
Publicado 2021

Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report

por Karim Souaid, Bénédicte Oulès, Pierre Sohier, Lydia Deschamps, Sélim Aractingi, Nicolas Dupin
Publicado 2021

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines

por Yang Wang, Yang Wang, Huaicheng Tan, Ting Yu, Xiaoxuan Chen, Fangqi Jing, Huashan Shi, Huashan Shi
Publicado 2021

Safety and efficacy of RNA vaccines: State of the art

por A. V. Blagov, A. A. Bukaeva, V. V. Makarov, Z. V. Bochkaeva
Publicado 2021

Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination

por Hamad Ali, Hamad Ali, Abdulmohsen Alterki, Abdulmohsen Alterki, Sardar Sindhu, Sardar Sindhu, Barrak Alahmad, Maha Hammad, Salman Al-Sabah, Mohammad Alghounaim, Mohammad H. Jamal, Ali Aldei, Mohammad J. Mairza, Maitham Husain, Sriraman Deverajan, Rasheed Ahmad, Preethi Cherian, Irina Alkhairi, Abdullah Alkandari, Jehad Abubaker, Mohamed Abu-Farha, Fahd Al-Mulla
Publicado 2021

Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy

por Layla Al-mansoori, Philip Elsinga, Sayed K. Goda
Publicado 2021

Sweet Syndrome Following SARS-CoV2 Vaccination

por Maria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, Francesca Montefusco, Stefano Senatore, Daniela Massi, Emiliano Antiga
Publicado 2021

Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine

por Chin-Shern Lau, Soon Kieng Phua, Ya-Li Liang, Helen May-Lin Oh, Tar-Choon Aw
Publicado 2021

RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement

por Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour, Anwar Abdelanser
Publicado 2021

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland

por Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Publicado 2021